NIH: Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)RFA-DA-15-007
Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support creative individuals who wish to pursue innovative research at the nexus of substance abuse and HIV/AIDS. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support research approaches for substance using populations with or at risk for HIV/AIDS that may lead to improved preventive interventions, improved therapies and/or long term retention in care, and ultimately, eradication of HIV.
USC may only submit one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White (email@example.com) by January 14, 2013. In addition to the 2-page abstract, you should also submit a biosketch for the PI.
NIH indicates that a letter of intent is Not Applicable and a full proposal is due by November 12, 2014. For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-007.html